...
【24h】

Low-cost flexible plasmonic nanobump metasurfaces for label-free sensing of serum tumor marker

机译:低成本柔性等离子体纳米泵Metasurface,用于无血清肿瘤标志物的无标签感测

获取原文
获取原文并翻译 | 示例

摘要

The use of plasmonic metasurface for sensing has great potential on label-free detection of human tumor markers, which could benefit clinical examination. In this work, we adopt nanoimprint and plasma etching to optimize the nanofabrication for low-cost flexible plasmonic metasurface sensors with gold nanobump arrays, which enable facile surface bio-functionality, high sensitivity and simple optical measurement in the visible range. A high bulk refractive index sensitivity of 454.4 nm/RIU is achieved for the prototype plasmonic metasurface sensors at the wavelengths from 620 nm to 720 nm. The rapid quantitative tumor marker sensing of carcinoembryonic antigen in human serum samples from less than 10 ng/mL to more than 87 ng/mL is achieved, which demonstrates good agreement with the conventional chemiluminescence immunoassay system and sufficiently covers the threshold tumor marker concentration of 20 ng/mL for early cancer prediction. Our method is capable of low-cost high-throughput manufacturing for flexible lightweight plasmonic metasurface sensors, which will facilitate wide applications on portable biomedical sensing devices for future point-of-care diagnosis and mobile healthcare.
机译:使用等离子体元表面进行感应的使用具有巨大的无标记检测人肿瘤标志物的潜力,这可能有利于临床检查。在这项工作中,我们采用纳米压印和等离子体蚀刻,以优化具有金纳盂阵列的低成本柔性等离子体元接口传感器的纳米制剂,其在可见范围内能够面向表面生物功能,高灵敏度和简单的光学测量。对于从620nm至720nm的波长的原型等离子体元表面传感器实现了454.4nm / Riu的高块折射率敏感性。实现了从小于10ng / ml的人血清样品中癌胚抗原的快速定量肿瘤标志物感测到超过87ng / ml,这表明了与常规化学发光免疫测定系统的良好一致性,并且充分地覆盖了20的阈值肿瘤标志物浓度Ng / ml用于早期癌症预测。我们的方法能够为柔性轻质等离子体元表面传感器提供低成本的高通量制造,这将促进便携式生物医学传感装置的广泛应用,以便将来的护理点诊断和移动医疗保健。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号